In three cases, systemic lupus erythematosus (SLE) occurred in association with the administration of ethosuximide. To our knowledge, this is the first report of SLE as a complication of ethosuximide therapy.
|Original language||English (US)|
|Number of pages||2|
|Journal||JAMA: The Journal of the American Medical Association|
|State||Published - May 20 1968|
ASJC Scopus subject areas